Oxford vaccine trial continues amid death report
- Country:
- United Kingdom
The University of Oxford says the late-stage trial of its COVID-19 vaccine in Brazil will continue following reports of a participant's death
The university said it can't comment on specific incidents but an independent review found no reason to be concerned about the safety of the Brazilian trial
It says an "independent review, in addition to the Brazilian regulator, have recommended that the trial should continue." The Oxford vaccine is being developed in conjunction with the international pharmaceutical company AstraZeneca. Trials are underway in the United States and the UK, as well as Brazil, to determine whether the potential vaccine is safe and effective in humans.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Brazilian